HPS Pharmacies wish to give notice that Pfizer Australia is experiencing a supply interruption for dobutamine injection as follows:
DBL™ Dobutamine Vial
Normal supplies are expected to resume in mid-June 2020. To ensure continuity of supply, Pfizer Australia has arranged an alternative dobutamine injection to be available for substitution under Section 19A of the Therapeutic Goods Act 1989.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Pfizer Australia on 1800 629 921.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates